Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral microbiome is a diverse community of bacteria, fungi, viruses, archaea, and protozoa inhabiting the mouth—all of which interact with each other and with the human host. Modulation strategies, including the use of probiotics, prebiotics, bacterial replacement, antimicrobial agents, and photobiomodulation, aim to restore or maintain a healthy microbial balance. This balance is crucial for oral health (preventing diseases like caries and periodontitis) and also has implications for systemic health, influencing conditions such as diabetes, cardiovascular disease, gastrointestinal disorders, and cancer. Therapeutic modulation focuses on reducing pathogenic microbes while enhancing beneficial commensals through targeted interventions, but it is accompanied by various safety and efficacy considerations.
Promotion of beneficial commensal bacteria; Suppression of pathogenic bacteria (via bacteriocins, competitive exclusion); Biofilm modulation (inhibiting pathogenic biofilm formation)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral microbiome modulation.